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Abstract
Background: Given the rising incidence of cardiovascular diseases (CVDs) in Bangladesh, an improved
understanding of the epidemiology of CVD risk factors is needed. Therefore, we reviewed published studies
on CVD modifiable risk factors e.g., Type 2 Diabetes Mellitus (T2DM), hypertension (HTN), dyslipidemia
and smoking as well as studies on CVDs and conducted a meta-analysis of risk factors and disease prevalence.
Methods: We searched the GLOBAL HEALTH, MEDLINE, EMBASE 'BanglaJol' databases for all studies in
English on CVDs and its associated modifiable risk factors. Random effects meta-analysis methods were used
to estimate pooled prevalence. Results: There were 74 eligible studies (outcome: T2DM = 32, HTN = 24,
dyslipidaemia = 8 and smoking = 25; CVDs = 10). Due to high between study heterogeneity (p<0.001, I2>
95%) in the prevalence of CVD risk factors, we presented median and interquartile range (IQR) instead of the
pooled estimates as the summary measures. Median (IQR) prevalence of T2DM, HTN, dyslipidemia and
smoking were 5.9% (1.97%-8.25%); 15.1% (10.52%-17.60%); 34.35% (10.66%-48.50%) and 40.56%
(0.80%-55.95%), respectively. The prevalence of T2DM and dyslipidemia were significantly higher in urban
compared to rural populations (13.5 vs 6%, p<0.001; 41.5 vs 30%, p = 0.007, respectively). Conclusions: The
prevalence of risk factors for CVDs is high in Bangladesh, more so in urban areas. Ageing of the population
may be a factor but urbanization seems to have an influence, possibly related to changes in dietary and physical
activity patterns. Further research, in particular longitudinal studies, is needed to explore the complex
interaction of these factors and to inform policies and programs for the prevention and management of CVDs
in Bangladesh.
Publication Details
Fatema, K., Zwar, N. Arnold., Milton, A. Hasnat., Ali, L. & Rahman, B. (2016). Prevalence of risk factors for
cardiovascular diseases in Bangladesh: A systematic review and meta-analysis. PLoS One, 11 (8),
0160180-1-0160180-14.
This journal article is available at Research Online: http://ro.uow.edu.au/smhpapers/4321
RESEARCH ARTICLE
Prevalence of Risk Factors for Cardiovascular
Diseases in Bangladesh: A Systematic Review
and Meta-Analysis
Kaniz Fatema1,2*, Nicholas Arnold Zwar1, Abul Hasnat Milton3, Liaquat Ali4,
Bayzidur Rahman1
1 The School of Public Health and Community Medicine, Faculty of Medicine, The University of New South
Wales, Sydney, Australia, 2 Department of Epidemiology, Bangladesh University of Health Sciences
(BUHS), 125/1 Darus Salam, Mirpur, Dhaka-1216, Bangladesh, 3 Centre for Clinical Epidemiology and
Biostatistics (CCEB), The School of Medicine and Public Health, Faculty of Health and Medicine, The
University of Newcastle, Newcastle, NSW 2008, Australia, 4 Department of Biochemistry and Cell Biology,




Given the rising incidence of cardiovascular diseases (CVDs) in Bangladesh, an improved
understanding of the epidemiology of CVD risk factors is needed. Therefore, we reviewed
published studies on CVDmodifiable risk factors e.g., Type 2 Diabetes Mellitus (T2DM),
hypertension (HTN), dyslipidemia and smoking as well as studies on CVDs and conducted
a meta-analysis of risk factors and disease prevalence.
Methods
We searched the GLOBAL HEALTH, MEDLINE, EMBASE ‘BanglaJol’ databases for all
studies in English on CVDs and its associated modifiable risk factors. Random effects
meta-analysis methods were used to estimate pooled prevalence.
Results
There were 74 eligible studies (outcome: T2DM = 32, HTN = 24, dyslipidaemia = 8 and
smoking = 25; CVDs = 10). Due to high between study heterogeneity (p<0.001, I2> 95%) in
the prevalence of CVD risk factors, we presented median and interquartile range (IQR)
instead of the pooled estimates as the summary measures. Median (IQR) prevalence of
T2DM, HTN, dyslipidemia and smoking were 5.9% (1.97%-8.25%); 15.1% (10.52%-
17.60%); 34.35% (10.66%-48.50%) and 40.56% (0.80%-55.95%), respectively. The preva-
lence of T2DM and dyslipidemia were significantly higher in urban compared to rural popu-
lations (13.5 vs 6%, p<0.001; 41.5 vs 30%, p = 0.007, respectively).
Conclusions
The prevalence of risk factors for CVDs is high in Bangladesh, more so in urban areas. Age-
ing of the population may be a factor but urbanization seems to have an influence, possibly
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related to changes in dietary and physical activity patterns. Further research, in particular
longitudinal studies, is needed to explore the complex interaction of these factors and to
inform policies and programs for the prevention and management of CVDs in Bangladesh.
Background
The burden of cardiovascular diseases (CVDs) is rising in developing countries, particularly
low and middle income countries (LMICs), creating a major challenge for the health sector.
According to the World Health Organization (WHO) CVDs were the cause of 17.5 million
deaths (31% of all death) around the world in 2012, of which 80% occurred in LMICs [1], and
85% of all global disability arose from CVDs [2].
CVDs and its associated known risk factors account for 13.4% of disability adjusted life
years (DALYs) lost in Bangladesh [3]. The major CVD risk factors such as abnormal glucose
metabolism, high blood pressure, dyslipidemia, smoking, along with increasing age are well
established [2, 4]. Obesity constitutes major risks for CVDs both directly (through underlying
insulin resistance and inflammatory changes) and indirectly (through the effect on other
immediate risk factors like T2DM, dyslipidemia and HTN). After China and India, Bangladesh
has the highest prevalence of diabetes mellitus (DM) among LMICs (8.4 million or 10% of the
population) and the prevalence could increase by 13% by 2030 [5]. According to the INTER-
HEART study Bangladeshis had the highest prevalence of CVD risk factors among five South
Asian countries with the prevalence of self-reported history of hypertension (14.3%), abdomi-
nal obesity (43.3%), current and former smoking (59.9%), and the lowest prevalence for regular
physical activity (1.3%) and daily intake of fruits and vegetables (8.6%) [6]. In Bangladesh,
99.6% male and 97.9% females are exposed to at least one of the established risks of CVDs and
at risk of CVD at a younger age (below 40 years in men) [3, 7, 8].
Considering the increasing trend of CVD related mortality in Bangladesh there is a need to
understand the epidemiology of CVDs and its risk factors in the country. A few review studies
were conducted on the effect of type 2 diabetes mellitus (T2DM) and hypertension (HTN), but
not on other risk factors of CVD [9–11]. This systematic review explores the prevalence of
major CVD risk factors (T2DM, HTN, dyslipidemia and smoking) and their correlates in Ban-
gladesh with the aim of describing the overall epidemiology of CVD risk factors in Bangladesh.
Methods
Search strategy
Systematic literature search initially was conducted on the EMBASE, GLOBAL HEALTH,
MEDLINE databases and a country specific search engine “BanglaJol”. The search was limited
upto August 2014, without any language restrictions. In Embase, we inputted location: South
Asia and Bangladesh; and for outcome: “cardiovascular disease, diabetes mellitus, hyperten-
sion, dyslipidemia and smoking” and explored all fields. The “OR” Boolean operator was used
to combine within the outcome and used “AND” to combine across outcome and location.
After that instead of South Asia AND (“Bangladesh”[Emtree Terms] Explored [All Fields]). In
addition we also searched for obesity using OR (“obesity”[Emtree Terms] Explored [All
Fields]). We also conducted a hand search to find articles referenced in other studies.
Data extraction
We extracted the following information for each reviewed study and recorded data (summary
included in S1–S6 Tables) as follows:
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1. General information: First author’s name and publication year, title and journal name, study
place and location (i.e., urban or rural) and year of data collection,
2. Study design: Type of study, sampling pattern (i.e., random or non-random), sample size
and sample characteristics such as age, gender and race,
3. Study factors: prevalence of T2DM—fasting plasma glucose (FPG), and impaired glucose
tolerance (IGT); HTN–systolic and diastolic blood pressure (sHTN and dHTN); dyslipide-
mia–lower level of high density lipoprotein (HDL), and high level of total cholesterol, and
high level of total triglyceride (TG); Obesity—body mass index (BMI), waist circumference
(WC), waist hip ratio (WHR); and waist height ratio (WHtR) and smoking status with diag-
nostic criteria,
4. Analysis: calculation of prevalence with confidence intervals (CI) and p values.
Quality assessment
There is no standard quality assessment instrument for assessing the quality of cross-sectional
studies reporting prevalence of a condition. Based on the quality assessment criteria for obser-
vational epidemiological studies [12] we developed a checklist to categorically assess the quali-
ties of our included studies. The study quality was assessed in three domains: 1) definition of
study base 2) representativeness of the sample and 3) accuracy of outcome measurements. In
each domain the studies were categorised as of good, moderate or poor quality. The study base
was considered good if it was defined appropriately in terms of person, place and time of the
study population. If any of these criteria (i.e., person, place and time of study population) was
not clearly stated, the study base was considered moderately defined and if none of these was
clearly stated the study was deemed to have poor base.
If the study participants were selected randomly form the general population (not from a
hospital) with defined age group, the sampling was considered good. If the samples were
selected purposively from the general population the samples was thought to be of moderate
quality. Non-random hospital based samples were considered of poor quality.
Studies with good outcome measurement clearly stated the methods and used evidence
based established technique for the measurement. For example, a good quality study would
diagnose diabetes mellitus by using classification system of WHO or the American Diabetes
Association (ADA) or International Diabetes Federation (IDF) based criteria. Whether the test
was based on fasting [13] or 2-hr post-prandial glucose [14] or the specimen was either whole
blood or plasma. Studies with self-reported diabetes were considered of poor quality.
We did not estimate overall study quality because its use is controversial [15]. We used the
domain specific quality information to conduct sub-group meta-analysis in order to examine
heterogeneity.
Statistical analysis
We used ‘METAPROP’ command in Stata version 12.1 (StataCorp LP, College Station, TX) to
perform fixed and random effects meta-analysis of proportions. This routine provides proce-
dures for pooling proportions in a meta-analysis of multiple studies and/or displays the results
in a Forest plot. The confidence intervals are based on score (Wilson)[16] or exact binomial
(Clopper-Pearson) [17] procedures. Along with the pooled estimate this command also reports
the significance test of it and the between study heterogeneity. The heterogeneity is also quanti-
fied using the I2 statistics [18]. We considered low, moderate and high degrees of heterogeneity
based on the values of I2 as<25%, 25–75% and above 75% respectively [19]. Sub-group
A Systematic Review and Meta-Analysis on CVD Risk Factors
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analyses were performed according to criteria for disease diagnosis (e.g., for DM using both
fasting and 2hBG (2 hours blood glucose), fasting BG (blood glucose) only and only after glu-
cose (AG). We also compared pooled estimates across sub-groups using chi-squared test.
Results
Study selection
For all the articles that met the identification criteria, primary investigator (KF) initially
screened the titles and abstracts. The inclusion criteria for this screening were: i) prevalence or
incidence data available on either CVD or T2DM or HTN or smoking or dyslipidemia, ii) pub-
lished result up to August 2014. Initially after removal of duplication, 599 articles were identi-
fied as potentially eligible. Among these, 355 studies were excluded for the following reasons:
based on hospital data (n = 15) as the source population could not be identified to estimate
prevalence; not relevant with our objectives or had no prevalence data (n = 270), sample not
from Bangladeshis or Bangladeshi population living overseas (n = 69); and one study from a
non-human sample. Following review of the full text a total of 128 studies were excluded for
the following reasons: 41 were collected from hospital admitted patients or hospital registry or
samples of patient with particular diseases; articles based on study designs that did not allow to
estimate prevalence, eg., case-control (n = 15); case report (n = 3); mortality (n = 11); review
article (n = 35); review and letters to editor (n = 14); duplicate publication (n = 3); and data
cannot be separated from the table (n = 3). The remaining 116 articles were further examined.
The set criterion for inclusion in the meta-analysis was that the participants should be selected
from a general population and not from a hospital populations. Therefore, a total of 74 studies
(S1–S6 Tables) were used to calculate the pooled prevalence. Studies conducted on special pop-
ulations (e.g., elderly, pregnant), being hospital/ clinic-based, studies reporting the results of
larger studies as duplications were excluded from the meta-analysis (Fig 1).
Overall characteristics of the reviewed studies (n = 74)
Nationally representative data are coded from recent studies that come from the Bangladesh
Demographic and Health Survey (DHS) carried out in 2011. However the majority of these
studies were mostly conducted in Dhaka, followed by a limited number of studies in Chitta-
gong, Sylhet and Rajshahi. Therefore the data is limited to these four divisions out of seven
divisions in Bangladesh (S1 Fig).
Seventy percent of studies (n = 53) selected participants with a random procedure, imple-
mented at one of three levels: village/city ward, household, or individual. Another 12 studies
enrolled everyone who resided in a chosen geographic area and met the study eligibility criteria.
Six studies used a non-random sample and information on the sampling strategy could not be
ascertained for the remaining three studies. More than 80% of the studies (n = 61) selected the
sample from the general population. However, sampling from various types of working groups
as well as from tribal populations was also reported. The lower age limit for eligibility was set to
20 years in most of these studies, except in three studies where it was 10 years, 15 years and 18
years, respectively. The sample of the remaining ten studies came from older adults (age>50,
n = 3), working professionals (n = 5), and tribal population (n = 2). Sixty one studies had both
male and female participants, 2 had only women, 8 had only men and three did not provide
information on gender. Forty (52%) studies were conducted in rural areas, 20 in urban areas
(27%), and 16 had both urban and rural samples (21%). However considering the present epi-
demiological transition pattern in Bangladesh, the rural populations mentioned in these studies
were recruited from areas closer to urbanised areas and they can be more accurately described
as urbanizing rural.
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Operational definitions and overall outcome of the reviewed studies
TheWorld Health Organization, WHO-1980, the WHO -1999, or the American Diabetes
Association, ADA -1997 classification system were used to define T2DM for all studies [20,
21]. Its definition varied according to whether the test was either a fasting or 2-hr postprandial
glucose, or whether the specimen was either whole blood or plasma. T2DM was self-reported
in three studies and not defined in another study. Two studies had gestational diabetes mellitus
(GDM) as its outcome.
HTN was also defined in various ways across studies: (i) systolic blood pressure (SBP)140
mmHg or diastolic blood pressure (DBP)90 mmHg (n = 6), (ii) SBP140 and/or DBP90
and/or anti-hypertensive medication use (n = 4), (iii) SBP140 and DBP90 (n = 1), (iv) SBP
140 (n = 1), (v) DBP90 or medication use (n = 2), (vi) SBP135 or DBP85 (n = 2), (vii)
self-reported (n = 2), (viii) not specified (n = 4) (ix) by clinical staff (n = 1).
Fig 1. PRISMA diagram of the literature screening process.Numbers indicate the article count retained at
each step of the process.
doi:10.1371/journal.pone.0160180.g001
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The definition of dyslipidemia varied across studies: (i) TG 1.70, HDL<1.04 for men and
<1.29 for women (n = 1), (ii) TG 1.7, HDL<1.03 for men and<1.29 for women (n = 1),
(iii) high cholesterol>240mg/dl, high LDL>160 mg/dl, Low HDL<40mg/dl, high TG200
mg/dl and total Chol/total HDLC (>5.5) (n = 1), (iv) High cholesterol>200mg/dl, Low HDL
<40mg/dl, High TG150 mg/dl (n = 1), (v) self-reported (n = 1), (vi) not specified (n = 3).
The definition of current smoking was also confirmed through further questions including
information of past use, duration of use, age at start, number of sticks per day.
Only T2DM was reported in 13 studies, HTN as a sole outcome in 4 studies, only dyslipide-
mia in three studies and obesity two studies. Both T2DM and HTN were in three studies, obe-
sity and lipid abnormalities along with T2DM and HTN were in 11 studies. HTN or T2DM
with CVD were in two studies and chronic kidney disease or arsenic with six studies. Cardio-
vascular disease was considered as solitary outcome for six studies. Four studies coded self-
reported data only.
Estimates of prevalence
All the estimates are presented in the Forest plots. In these plots, each rectangle in the centre
represents the point estimates for individual study; the rectangle’s size corresponds to the point
estimates weight in the pooled estimate and the horizontal line through the rectangle repre-
sents width of the 95% confidence interval (CI) about the point estimate. Each diamond repre-
sents a pooled estimate; its vertical axis marks the point estimated and its horizontal extremes
the upper and lower 95% confidence bounds. Studies that had undue influence on the pooled
estimate were excluded from the forest plots [22]. We got very high between study heterogene-
ity (p<0.001, I2> 95%) was reported in the prevalence of CVD risk factors. Therefore, we pre-
ferred median and interquartile range (IQR) to the pooled estimates as the summary measures.
T2DM (n = 32). Overall median prevalence was 5.9%, IQR: 1.97%-8.25% and pooled prev-
alence of 7.0%, (I2 = 99.0%, p<0.001). The very high heterogeneity relates to the findings from
two studies. One of these reported prevalence in three geographic areas [23], one of which was
very high. The other study [24] used a stratified sampling method (e.g., participants through a
multi-stage random sampling procedure, from a middle-income neighbourhood in the capital
city of Dhaka). If we exclude these two study findings & re-analyse, the pooled prevalence
within strata based on DM (diagnosed from both F and 2hBG) becomes 5.0% (95% CI: 4.0%–
6.0%, I2: 98.3%). Within strata based on fasting the pooled prevalence for T2DM was 9.0%
(95% CI: 6.0%–13.0%, I2: 97.8%) and based on after glucose tolerance test it was 5.0% (95% CI:
3.0%–7.0%, I2: 88.9%). Overall T2DM prevalence estimate was 6.0% (95% CI: 5.0%–7.0%, I2:
98.0%) (Fig 2A).
HTN (n = 24). Overall median prevalence was 15.1%, IQR: 10.52%-17.60% and pooled
prevalence of both systolic HTN (sHTN) and diastolic HTN (dHTN) was 13.0% (95% CI:
11.0%–16.0%) with I2: 99.6% and p<0.001. Based on systolic blood pressure only, the pooled
prevalence was 15.0% (95% CI: 11.0% to 18.0%, I2: 69.1%) and based on diastolic blood pres-
sure, it was 13.0% (95% CI: 9.0%–16.0%, I2: 95.8%). Overall the HTN prevalence estimates was
14.0% (95% CI: 11.0%–16.0%, I2: 99.5%) (Fig 2B).
Dyslipidemia (n = 8). Overall median prevalence was 34.35%, IQR: 10.66%-48.50% and
pooled prevalence for high cholesterol was 23.0% (95% CI: 17.0%–30.0%) with I2: 96.5% and
p<0.001). The prevalence of elevated LDL from one study in rural areas was 30.0% (95% CI:
12.0%–44.0%). However the low HDL pooled prevalence was 52.0%, with I2 = 99.9% and
p<0.001. As the defined cut off value for low HDL and laboratory procedure varied we kept
the result as it is. Prevalence of High TG and cholesterol/HDL ratios (from one study) were
37.0% (95% CI: 26.0%–48.0%, I2: 98.4%) and 33.0% (95%CI: 28.0%–37.0%). Overall
A Systematic Review and Meta-Analysis on CVD Risk Factors
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dyslipidemia pooled prevalence was 18.0% (95% CI: -0.0%– 31.0%, I2: 99.4%). High heterogene-
ity was noted and we observed three studies reported very high prevalence of low HDL which
stands out from of all other studies and the study covered both urban and rural population [25–
27]. Overall dyslipidemia prevalence estimate was 34.0% (95% CI: 24.0%–43.0%, I2: 98.9%).
In addition, we also observed obesity although it is not an established risk factor for CVD as
are the others.
Fig 2. a: Prevalence of diabetes mellitus in Bangladesh; b: Prevalence of hypertension in Bangladesh; c: Prevalence of dyslipidemia in
Bangladesh; d: Prevalence of smoking in Bangladesh (according to gender); e: Prevalence of smoking in Bangladesh (according to study
places).
doi:10.1371/journal.pone.0160180.g002
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Obesity (n = 15). Considering BMI as obesity indicator, median prevalence (cut-off value
>25.01) was 16.02%, IQR: 7.9%-47.3% and pooled prevalence was 15.0% (95% CI: 11.0%–
20.0%) with I2: 99.7% and p<0.001. This is due to a study with very high prevalence that
included both urban and rural and the pooled prevalence became 10.0% (95% CI: 8.0%–12.0%,
I2: 98.7%). Pooled prevalence of obesity defined by WC (>0.90 male,>0.80 female) was 21.0%
(95% CI: 13.0%–28.0%). Obesity defined by WHR (>1.0 male,>0.85 female), a study [28]
reported very high prevalence among rural participants and after excluding it, pooled preva-
lence was 55.0% (95% CI: 47.0%–62.0%, I2: 99.3%). Prevalence of waist to height ratio (>0.5)
from one study was 60.0% (95% CI: 58.0%–62.0%). Considering obesity from any of the mark-
ers, we estimated overall obesity, the pooled prevalence was 24.0% (95% CI: 18.0%– 30.0%, I2:
99.9%) (S2 Fig).
Smoking (n = 25). Overall median prevalence of smoking was 40.56%, IQR: 0.80%-
55.95% and pooled prevalence was 33.0% (95% CI: 32.0%–34.0; I2 = 100% and p<0.001).
Among males, the pooled prevalence was 50.0% (95% CI: 37.0%–63.0%, I2: 100%) and females
it was 6.0% (95% CI: 5.0%–7.0%, I2: 99.7%). From combined gender studies the prevalence esti-
mates was 39.0% (95% CI: 17.0%–61.0%, I2: 99.8%). However pooled prevalence based on
area-wise smoking was 40% (95% CI: 35.0%–44.0%). In the rural areas, the pooled prevalence
was 35.0% (95% CI: 28.0%–41.0%, I2: 99.6%) and in the urban areas, it was 44.0% (95% CI:
31.0%–57.0%, I2: 99.4%). Pooled estimate, from studies reporting prevalence in urban and
rural areas combined, was 40.0% (95% CI: 34.0%–47.0%, I2: 99.9%).
To explore the cause of heterogeneity, a quality assessment (as per study base, method of
sample selection and measurement of outcome) of the studies was performed (Table 1). Ini-
tially we conducted a subgroup (i.e., poor, moderate and good) analysis and meta-regression to
examine the difference in pooled estimates among study qualities for T2DM, HTN, dyslipide-
mia and obesity. We did not find a significant effect of these quality domains on the pooled
estimates for the prevalence of T2DM, HTN, dyslipidemia and smoking.
We also explored the cause of heterogeneity according to study population (i.e., semi urban,
urban, rural, and both) following the same steps as study quality. We observed a significant
effect of the study population on the prevalence of T2DM. In the urban areas, the prevalence
was three times higher than rural areas (p<0.001) and for dyslipidemia, it was 2.5 times higher
(p = 0.007). No significant effect of area was observed on the prevalence of HTN (p = 0.31). For
Table 1. Quality assessment of the studies and area wise distribution of the published papers.
*Phase 1: Study base (%) Sample selection Method (%) Outcomemeasurement (%)
Good Moderate Poor Good Moderate Poor Good Moderate Poor
Diabetes (n = 28) 29 43 29 25 36 39 86 3 11
Hypertension (n = 24) 17 58 25 17 46 38 79 13 8
Dyslipidaemia (n = 8) 12.5 37.5 50 - 38 62 62.5 25 12.5
Smoking (n = 25) 17 37.5 46 29 29 42 46 46 8
CVD (n = 10) 30 40 30 - 50 50 70 20 10
†Phase 2: Urban (%) Rural (%) Urban and rural (%) Semi urban (%)
Diabetes (n = 28) 25 60.7 10.7 3.6
Hypertension (n = 24) 25 67 8 -
Dyslipidemia (n = 8) 50 37.5 12.5 -
Smoking (n = 25) 24 36 40 -
CVD (n = 10) 10 50 40 -
* Study quality evaluated by following the checklist for this study.
† Area wise selected study distribution.
doi:10.1371/journal.pone.0160180.t001
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smoking, there was no difference between rural and urban areas but combined urban and rural
studies showed more than two times higher prevalence than rural areas (p<0.010). No trend
analysis has been performed due to lack of sufficient data for any risk factor. Sensitivity analy-
ses have been done with age group and sex but no difference was found except smoking. There-
fore, the results are not presented.
Assessment of variables associated with CVD risk factors and CVDs
There were 19 studies (excluding two studies for duplicate publication) that reported T2DM-
related covariates information. These studies reported the prevalence of diabetes was positively
associated with male gender, age, family history of DM, higher income or socioeconomic class,
physical activity level / sedentary lifestyle, BMI, WHR, waist girth, WHtR, and as a whole, gen-
eral and central obesity, SBP, hypertension, total cholesterol and triglyceride.
Twelve studies reported covariates of HTN-related data. HTN showed significant positive
association with increased age, female gender, 2h BG / hyperglycaemia, higher educational
status, urban areas, upper socio-economic class, BMI, WHR, WHtR, overall obesity, animal
protein, dietary pattern (concentrations of salt, sugar, trans-fats and saturated fats in manufac-
tured food products). Longitudinal studies that were conducted in the arsenic contaminated
areas showed positive association between HTN and high arsenic concentration in drinking
water or duration of exposure with a dose-response relationship. However, none of the articles
of dyslipidemia and obesity related to the risk of CVDs reported data on their covariates.
Only 13 studies reported covariates of smoking related data. Smoking showed significant
positive association with increased age, lower level of education, unemployment status, place of
residence, marital status, having STDs, premarital and extra marital sex, religion [non-Muslim
(i.e., Hindu/ Christian/ others)], illegal drug use, poverty.
Covariates data of CVDs have been reported in four studies. Among those, three of the stud-
ies reported coronary artery disease and the fourth study included stroke in addition to this.
Hypertension, age, central obesity defined byWHR, male gender, social class, 2h after blood glu-
cose, albumin creatinine ratio (ACR) and family history were positively associated with CVDs.
Discussion
The present study systematically evaluates cross sectional studies on the prevalence of CVD
risk factors and the prevalence of CVDs among the Bangladeshi population. The pooled preva-
lence estimates obtained for T2DM and HTN were similar to a previous study [9]; that is, 5.9%
and 15.1%, respectively. For dyslipidemia and smoking it was 34.35% and 40.56%, respectively.
Both T2DM (p<0.001) and dyslipidemia (p = 0.007) were higher in urban than rural areas.
T2DM has been better studied in Bangladesh compared to the other immediate CVD risk
factors. The pooled prevalence from these studies is significantly lower than the recent nation-
wide survey in adults (10%) [29]. Multiple factors, such as method of blood sugar measurement
for diabetes and diagnostic criteria used for T2DM, are likely to explain this variation. We
found that the prevalence of T2DM ranges from 5%–7% in rural areas whereas, 10%–17% in
urban areas. The rural prevalence is slightly higher than that in South India and Pakistan (less
than 5%), but it is considerably higher than China (3%) [30]. The differences in prevalence’s
among various populations become less prominent when those are estimated in urban settings
(Sri Lanka 6%–14%, South India ~12%) [30]. Indian migrants in Mauritius, Fiji, Singapore and
Tanzania, who adopted a more urbanized life showed a greater prevalence (15%–20%) [30].
The prevalence of HTN was found to be 10%–16% in rural Bangladeshi people, slightly
higher (12%–25%) in urban areas and, overall, 13%-18% among the adult population. This is
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less than South Asian countries such as Bhutan (23.9%), India (31.45%), Nepal (31.5%), Paki-
stan (33.8%), and Sri Lanka (25%) [12].
In contrast to marked differences in rural-urban distribution of HTN, the pooled prevalence
of dyslipidemia (with any one lipid being abnormal) was only slightly different, e.g., 8%–42%
in rural and 34%–49% in urban areas. Analysis of individual lipids shows pro-atherogenic pro-
file (high cholesterol and high TG). However, lack of reliable data on LDL and HDL precludes
any conclusion on these two lipids, especially on the LDL/HDL ratio which is considered as
one of the major determinants of CVD risk. High dyslipidemia markers have been observed
among South Asians, including Bangladeshis, when compared with the European and Chinese
populations in a Canadian study [31]. Additionally, overweight and obesity constitute major
risks for CVDs both directly and indirectly. It is evident that generalized obesity (predomi-
nantly measured by BMI) is still low in Bangladesh, in both rural (18%–36%) and urban (18%–
28%) areas. However, measurement of central obesity by using waist circumference shows a
higher value (13%–28%) and its assessment by WHR shows an alarmingly high value (45%–
57%) (S2 Fig). We found the rural and urban pooled prevalence to be almost similar (18%–
36% vs 18%–28%).
Tobacco consumption has been relatively well studied among Bangladeshis. While only
5%–7% females (both in rural and urban areas) are smokers, the proportion among males is
high (37%–63%). The proportions do not differ markedly between urban and rural areas
(29%–49% vs 26%–37%). Smokeless tobacco use (ingested with betel leaf or chewed or sniffed
as powder) was common, particularly among the poor and in rural areas, irrespective of gender
[32, 33]. Studies on the strength of the association of tobacco consumption, particularly smoke-
less tobacco, with CVDs, however, are not yet available.
Due to the methodological heterogeneity of diagnostic criteria and the exclusion of hospital
studies in this research, generalizing evidence on the prevalence of CVDs is difficult. However,
some research findings do suggest that the pooled prevalence of CVDs is quite high (24%-26%)
among the Bangladeshi population [34, 35]. The average estimates are higher in Bangladesh
than those of India (12%–27%) and Pakistan (around 20%) but considerably lower than those
of Sri Lanka (31%–44%) [30].
Urbanization, an important underlying factor, was identified as the most common in all
cases that have high prevalence of the CVD’s immediate risk factors. It is not possible to
directly assess the effect of urbanization on the individual risk factors due to the lack of longitu-
dinal data. However, the overall rural-urban distribution of CVDs risk factor prevalence raises
issues which need greater attention. The urban population in Bangladesh has been growing on
an average of 3.5% per year [36]; which is associated with unplanned industrialization [37].
The living standard of most of the cities has been reported to be falling [36] and the urban
areas are experiencing a decline in air quality [38]. This kind of urbanization may also be con-
ceived to be associated with unhealthy diet and less physical activity, leading to excessive
weight gain, and, also, with increased stress and anxiety which, directly or indirectly, may affect
other behavioral factors such as smoking [39].
Strengths and limitations
Most of the studies on CVD risk factors have been conducted in and around Dhaka division
and a few were in Sylhet, Chittagong and Rajshahi, four out of the seven divisions in Bangla-
desh. Thus, the findings may not be nationally representative. The urban data samples were
not representative enough as participants had common environments (i.e., health care profes-
sionals, government employees, slum dwellers) [40–42] that were crucial. Moreover, the rural
samples were demographically diverse yet geographically limited to particular villages, and
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therefore were not representative of the thousands of other villages of the country. Most of the
large scale studies, with an adequate number of samples, have been conducted by non-govern-
ment organizations with some international collaboration. This can result in biases in popula-
tion selection and recruitment. Probable overestimation or underestimation of health
conditions prevailed as samples were taken depending on the availability of laboratory facilities
and data were taken from surveys based on self-reported information or medical examinations
conducted for self-reported diseases. It was evident that high heterogeneity rose from the study
quality and participants’ inclusion criteria that may have resulted in relatively weaker
conclusions.
The main strength of our study is that we were able to include all the eligible studies through
comprehensive search of the international and local databases without any language restriction.
We used a comprehensive 'quality scoring instrument' to assess the quality of the included
studies to incorporate in the analyses. We had large number of studies that reported prevalence
separately for urban/rural and male/female which facilitated comparisons across the groups.
Recommendations / further research areas
This study provides paradoxical findings i.e., both obesity and smoking do not differ between
urban and rural areas as rest of the risk factors do. Larger scale studies with appropriate design
(e.g., prospective cohort studies) are required to resolve this paradox. To date, no study has
reported the impact of socioeconomic, environmental, nutritional and lifestyle factors affecting
the CVDs and its immediate risk factors. In the past 20 years, substantial socioeconomic and
demographic change has occurred in Bangladesh, and the economy has shifted gradually from
a completely agricultural economy to one with a growing reliance on the industrial sector,
resulting in an urbanizing effect on rural lifestyle [43]. Longitudinal studies are required to
examine the impact of the sociodemographic and epidemiological transition on CVD risk.
Nationally representative large scale studies with greater accuracy in the estimation of such
kind of changes along with the precise subcomponents and assessment of their contribution on
individual CVD risk factors will greatly assist in improving policy and program planning in the
public health sector of Bangladesh.
Conclusions
The prevalence of risk factors of CVDs, namely T2DM, HTN, dyslipidemia, obesity and smok-
ing are quite high in Bangladesh and are generally higher than in the neighbouring countries.
The ageing of the population is a very likely factor but urbanization may also have an influence
on CVD risk through changes in dietary pattern and physical activity. Further research, in par-
ticular longitudinal studies, may help greatly in understanding the complex interaction of these
factors. These studies may help designing policies and programs for the management and pre-
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